Gabriel Hancu

Profens are chiral nonsteroidal anti-inflammatory drugs (NSAIDs) whose enantiomers may differ in pharmacokinetics, pharmacological activity and pharmacotoxicological profile, making enantioselective analysis relevant for pharmaceutical quality control and bioanalytical applications. Capillary electrophoresis (CE) has been extensively investigated for their enantioseparation because of its high efficiency, low sample and reagent consumption, and the possibility of easily modifying the chiral recognition environment. This review traces the development of CE methods for profen enantioseparation from early exploratory studies focused on chiral selector (CS) screening to the most recent reports available up to 2026, highlighting the progressive shift toward quantitative, validated, and application-oriented methods. The influence of CS type and concentration, background electrolyte (BGE) composition and pH, organic modifiers, polarity, and capillary surface modification is discussed in relation to enantioselectivity and analytical performance. Although cyclodextrin (CD)-based systems remain predominant, the available literature shows that profen enantioseparation is strongly analyte-dependent and that no single CS or set of conditions is universally applicable. The review also examines the transition from proof-of-concept enantioseparation toward validated methods for enantiomeric impurity determination, configurational stability assessment, and the analysis of pharmaceutical, biological, and environmental samples, while highlighting the analytical performance and current limitations of CE-based approaches. Future developments should focus on improving sensitivity, robustness, and applicability to complex matrices while making greater use of rational CS selection, multivariate optimization, and complementary detection approaches.

Antimicrobial resistance is a major global health challenge that has created an urgent need for new antibacterial agents capable of overcoming emerging resistance mechanisms. Among nitrogen-containing heterocycles, pyrrolidine has been widely investigated in medicinal chemistry due to its structural versatility, favourable physicochemical properties, and ability to enhance interactions with biological targets. This review provides a comprehensive and critical overview of pyrrolidine-based compounds investigated for antibacterial applications. Relevant studies describing clinically approved antibiotics, natural products, synthetic derivatives, hybrid molecules, and antibacterial adjuvants containing a pyrrolidine scaffold were collected, classified, and critically evaluated, with particular emphasis on structural features, antibacterial activity, and structure–activity relationships. The reviewed evidence demonstrates that the pyrrolidine moiety is present in several antibacterial drug classes, including carbapenems, cephalosporins, fluoroquinolones, lincosamides, streptogramins, and tetracyclines, where it contributes to improved target affinity, antibacterial potency, and pharmacokinetic behaviour. Numerous recently reported pyrrolidine derivatives have shown promising activity against clinically relevant, multidrug-resistant bacterial pathogens. The pyrrolidine scaffold is valuable for the design of next-generation antibacterial agents and resistance-modifying compounds, though further in vivo studies and pharmacological evaluation are required to support their clinical development.

Azelaic acid (AZA) and salicylic acid (SA) are widely used active ingredients in pharmaceutical and cosmetic formulations for the treatment of acne, rosacea, hyperpigmentation, and other dermatological conditions. Despite their frequent co-administration, analytical methods for their simultaneous determination remain limited. In the present study, a capillary electrophoresis (CE) method with indirect UV detection was developed and validated for the simultaneous determination of AZA and SA in pharmaceutical and cosmetic preparations. Preliminary experiments demonstrated that direct UV detection was unsuitable because of the weak UV absorbance of AZA; therefore, indirect UV detection based on a sodium benzoate background electrolyte (BGE) was used. Following an initial one-factor-at-a-time (OFAT) screening, method optimization was performed using a face-centered central composite design (CCD) to evaluate the effects of BGE concentration, BGE pH, and separation voltage on the separation. The optimum separation was achieved using a 30 mM sodium benzoate BGE at pH 6.5 containing 5% (v/v) methanol, a separation voltage of +18 kV, a capillary temperature of 20 °C, and indirect UV detection at 230 nm. Baseline separation of both analytes was achieved within 5 min. The method was validated according to the ICH Q2(R2) guideline and demonstrated satisfactory accuracy, linearity, precision, selectivity, sensitivity, and robustness. The developed procedure was successfully applied to the analysis of commercial cosmetic formulations containing AZA, SA, or both active ingredients, providing assay results consistent with the declared contents. The proposed CE method provides a simple, rapid, cost-effective, and environmentally friendly alternative for the routine quality control of pharmaceutical and cosmetic formulations containing AZA and SA.

Background/Objectives: Mental and neurological disorders contribute substantially to the global burden of disease, affecting people of all ages and backgrounds. As their prevalence increases with age, their overall impact is expected to grow in the coming decades. Although psychological and pharmacological treatments are available, many patients fail to achieve satisfactory outcomes, underscoring the need for improved therapeutic strategies. Cannabis sativa L. has been used for medicinal purposes for centuries, and cannabidiol (CBD) has attracted increasing attention because of its broad therapeutic potential. Scientific studies indicate that CBD may be beneficial in several mental and neurological disorders. Methods: A comprehensive literature search was conducted to identify articles investigating the therapeutic potential of CBD and cannabis in selected disorders. Results: Evidence from preclinical and clinical studies, together with findings from the broader cannabis literature, indicates that CBD may offer therapeutic benefits in a range of conditions, including Alzheimer’s and Parkinson’s disease, anxiety disorders, and epilepsy. Emerging data also support its potential use as an adjunctive therapy for COVID-19. Current research has improved understanding of the neurobiological mechanisms underlying these disorders and the molecular pathways through which CBD may exert its effects. CBD has demonstrated good tolerability, with predominantly mild adverse effects and a favorable safety profile. Conclusions: Despite promising findings, many available studies are preclinical or involve small patient cohorts, and the mechanisms underlying the therapeutic effects of CBD remain incompletely understood. Further well-designed, randomized, controlled, multicenter trials are needed to establish the efficacy and safety of CBD and support its integration into clinical practice.

Dapagliflozin (DAPA), a selective sodium–glucose cotransporter 2 inhibitor, is widely used in the management of type 2 diabetes mellitus, with additional indications in heart failure and chronic kidney disease. The growing analytical demand for DAPA determination in pharmaceutical formulations, fixed-dose combinations, and biological matrices has stimulated the development of diverse analytical methods. This review provides a comprehensive evaluation of reported techniques for DAPA quantification in different matrices. Approaches discussed include chromatographic methods (TLC, RP-HPLC, UHPLC, LC-MS/MS), electromigration techniques (CE), and spectroscopic methods (UV–Vis, spectrofluorimetry). Emphasis is placed on key performance characteristics such as selectivity, sensitivity, linearity, robustness, and applicability to stability studies and bioanalysis. Recent trends, including the application of Quality by Design, green analytical chemistry principles, and advanced hyphenated techniques, are also addressed. While RP-HPLC remains widely used for routine quality control due to its robustness and accessibility, LC-MS/MS is generally regarded as the method of choice for trace-level bioanalysis owing to its superior sensitivity and selectivity. CE and spectroscopic techniques offer cost-effective and environmentally friendly alternatives, though with certain limitations. This review highlights current methodological gaps and outlines future directions for developing more sensitive and sustainable analytical strategies.

A micellar electrokinetic chromatography (MEKC) method was developed and validated for the simultaneous determination of dapagliflozin (DAPA) and metformin (MET) in pharmaceutical formulations. Due to the markedly different physicochemical properties of the two antidiabetic drugs, conventional capillary zone electrophoresis failed to provide adequate selectivity. This limitation was overcome by introducing MEKC, enabling the selective separation of a neutral and a highly polar cationic analyte. Following an initial one‐factor‐at‐a‐time screening, critical experimental parameters were systematically optimized using a Box–Behnken design, evaluating the influence of sodium dodecyl sulfate (SDS) concentration, separation voltage, and capillary temperature on DAPA migration time, MET peak symmetry, and generated current. Optimized separation was achieved using a 25 mM borax buffer (pH 9.3) containing 38 mM SDS, a separation voltage of 28 kV, and a capillary temperature of 25°C, with ultraviolet detection at 210 nm. Under these conditions, complete separation was obtained within 7 min. The method exhibited good linearity over concentration ranges of 0.02–0.20 mg mL ^{− 1} for DAPA and 0.1–1.00 mg mL ^{− 1} for MET, with satisfactory precision, accuracy, and sensitivity. Robustness evaluation using a Plackett–Burman design confirmed the stability of the method. The method was successfully applied to the analysis of commercial fixed‐dose combination tablets, yielding assay results consistent with labeled claims. The developed method represents a rapid, reliable, and environmentally favorable alternative to conventional chromatographic approaches for the routine quality control of fixed‐dose antidiabetic formulations.

Cellulite, a multifactorial condition affecting approximately 98% of women, is characterised by dermal and subcutaneous architectural changes that compromise skin texture and elasticity. Its progression is closely linked to hormonal, vascular, and inflammatory factors, as well as ageing-related extracellular matrix degradation. This review critically evaluates bioactive compounds incorporated into topical and minimally invasive formulations for the management of cellulite and skin rejuvenation. A comprehensive literature search was conducted across major scientific databases and cosmetic ingredient repositories, focusing on active ingredients with demonstrated efficacy in enhancing skin structure. Key compounds include capsaicin, forskolin, L-carnitine, caffeine, retinol, and extracts from plants such as Centella asiatica, which act via lipolysis, improved circulation, and antioxidant effects. Minimally invasive agents, such as deoxycholic acid and poly-L-lactic acid, complement these strategies by inducing adipocytolysis and neocollagenesis, thereby improving skin firmness and contour. Evidence indicates that multi-active formulations combining lipolytic agents with antioxidants and collagen-stimulating molecules yield synergistic benefits, reducing adipose protrusion and improving skin firmness. However, heterogeneity in study design and the lack of standardised evaluation methods limit firm conclusions. Further studies should validate efficacy and optimise delivery. Integrated topical and injectable therapies represent a promising, multifunctional approach to addressing cellulite and age-related skin changes.

Acne vulgaris is a prevalent dermatological disorder characterized by excessive sebum production, impaired skin hydration, enlarged pores, and persistent lesions. Chemical peeling is a well-established procedure in cosmetic dermatology, while microneedling has emerged as a promising minimally invasive procedure; however, evidence on their combined use remains limited. This pilot study aimed to compare the efficacy of chemical peeling, combined chemical peeling with microneedling, and a classic cosmetic protocol in patients with mild to moderate acne. Fifteen participants aged 18–45 years were divided into three groups according to the treatment protocol. Groups 1 (chemical peeling) and 3 (classic cosmetic care) each received four sessions at two-week intervals, whereas Group 2 (combined peeling with microneedling) completed seven sessions. Sebum levels, hydration, pore counts, and acne lesions were assessed using digital skin analysis and evaluated statistically by one-way ANOVA followed by Tukey’s HSD test (p < 0.05). Chemical peeling reduced sebum secretion (−17–18%) and acne lesions (−14%) and increased hydration (+22%), although pore counts increased (+8–18%). The combined protocol achieved the most pronounced seboregulation (−23–25%) and lesion reduction (−22%) with pore reduction (−7%), but hydration decreased (−14–19%). The classic treatment produced only modest effects, mainly a slight decrease in sebum (−10%) and lesions (−8%), accompanied by dehydration (−23–26%) and increased pore counts (+14–16%). These findings indicate the efficacy of chemical peeling and its enhancement through combination with microneedling, emphasizing the need for individualized cosmetic strategies and further validation in larger controlled trials.

The endocannabinoid system (ECS) is a vital biological network essential for maintaining homeostasis and supporting various physiological functions. It comprises cannabinoid receptors, endogenous lipid-based ligands, known as endocannabinoids, as well as metabolic enzymes and associated proteins responsible for regulating their levels within tissues. The ECS plays a central role in modulating processes involving the central nervous system (CNS). Recent studies have highlighted its antioxidant, anti-inflammatory, and neuroprotective properties. The therapeutic potential of cannabinoids, particularly phytocannabinoids derived from plants, has attracted significant attention in medical and pharmaceutical research. This interest has grown in parallel with the increasing availability of cannabinoid-based food supplements on the pharmaceutical market. Given the complexity of the ECS and its broad range of interactions, the discovery of this system has spurred extensive investigations into the use of cannabinoids for various health conditions. In this review, we examine recent preclinical evidence supporting the use of phytocannabinoids in the context of neurodegenerative diseases, particularly in Alzheimer’s disease and Parkinson’s disease. Targeting the ECS through phytocannabinoid-based pharmacological modulation offers a promising therapeutic strategy for these neurological disorders. Among these compounds, cannabidiol has emerged as a key focus of research due to its multifaceted effects and favorable safety profile. Nonetheless, continued investigation is necessary to clarify its mechanisms of action, and to develop effective, evidence-based clinical applications.

Chitosan (CS), a versatile biopolymer obtained through the deacetylation of chitin, has gained significant interest in biomedical and pharmaceutical applications due to its biocompatibility, biodegradability, and unique gel-forming capabilities. This review comprehensively analyzes CS-based gel development, covering its extraction from various natural sources, gelation mechanisms, and biomedical applications. Different extraction methods, including chemical, biological, and green techniques, are discussed regarding efficiency and sustainability. The review explores the physicochemical properties of CS that influence its gelation behavior, highlighting various gelation mechanisms such as physical, ionic, and chemical cross-linking. Recent advances in gel formation, including Schiff base reactions, Diels–Alder click chemistry, and thermosensitive gelation, have expanded the applicability of CS hydrogels. Furthermore, CS-based gels have demonstrated potential in wound healing, tissue engineering, drug delivery, and antimicrobial applications, offering controlled drug release, enhanced biocompatibility, and tunable mechanical properties. The incorporation of nanomaterials, bioactive molecules, and functional cross-linkers has further improved hydrogel performance. The current review underscores the growing significance of CS-based gels as innovative biomaterials in regenerative medicine and pharmaceutical sciences.